{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:10:05Z","timestamp":1788948605670,"version":"build-2803163510"},"reference-count":8,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>As Guest Editors for the Special Issue \u201cAdvances in Vaccine Adjuvants,\u201d we are pleased to offer this closing editorial [...]<\/jats:p>","DOI":"10.3390\/vaccines14090787","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:24:02Z","timestamp":1788945842000},"page":"787","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Closing Editorial: Special Issue on \u201cAdvances in Vaccine Adjuvants\u201d"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-4450","authenticated-orcid":false,"given":"Surabhi","family":"Gautam","sequence":"first","affiliation":[{"name":"Department of Anatomy, Faculty of Medicine and Health Sciences, SGT University, Gurugram 122505, Haryana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8181-3999","authenticated-orcid":false,"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5285-7725","authenticated-orcid":false,"given":"Devyani","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Shi, Z., Xi, J., Cui, M., Wan, Z., Hou, Y., Ma, Z., Sun, N., Zhu, Y., Li, M., and Wang, D. (2026). Rational Combination of Dominant and Subdominant Antigens with Nanoadjuvant Elicits Durable Immunity Against Staphylococcus aureus. Vaccines, 14.","DOI":"10.3390\/vaccines14020169"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zdrehus, R.-S., Mocan, T., Sabau, L.I., Matea, C.T., T\u0103b\u0103ran, F., Pop, T., Delcea, C., Mosteanu, O., and Mocan, L. (2025). CEA-Functionalized Gold Nanoparticles as a Nanovaccine Platform: In Vitro Evaluation of Cytocompatibility, Cellular Uptake, and Antigen Processing. Vaccines, 13.","DOI":"10.20944\/preprints202505.0830.v1"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ghattas, M., Dwivedi, G., Chevrier, A., Scobey, T., El-Mayta, R., Mattocks, M.D., Wang, D., Lavertu, M., and Alameh, M.-G. (2025). Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy. Vaccines, 13.","DOI":"10.3390\/vaccines13080788"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kanjo, K., Lothe, R., Nagar, G., Rajurkar, M., Rao, H., Batwal, S., Shaligram, U., and Varadarajan, R. (2025). Destabilising Effect of Class B CpG Adjuvants on Different Proteins and Vaccine Candidates. Vaccines, 13.","DOI":"10.3390\/vaccines13040395"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"D\u2019onofrio, V., Jacobs, B., Alhatemi, A., De Gussem, S., Verstraete, M., Porrez, S., Willems, A., De Boever, F., Waerlop, G., and Leroux-Roels, G. (2025). A novel carbohydrate fatty-acid monosulphate ester, squalane-in-water adjuvant is safe and enhances inactivated influenza vaccine immunogenicity in older adults. Vaccines, 13.","DOI":"10.3390\/vaccines13090922"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Arte, T.M., Patil, S.R., Adediran, E., Singh, R., Bagwe, P., Gulani, M.A., Pasupuleti, D., Ferguson, A., Zughaier, S.M., and D\u2019souza, M.J. (2025). Microneedle Delivery of Heterologous Microparticulate COVID-19 Vaccine Induces Cross Strain Specific Antibody Levels in Mice. Vaccines, 13.","DOI":"10.3390\/vaccines13040380"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yao, S., Zhai, Z., Liao, L., Zhong, L., Shi, C., Cheng, Y.-X., and Liu, X. (2026). Intranasal Vaccine Adjuvants and Delivery Platforms: From Barrier Mechanisms to Clinical Translation. Vaccines, 14.","DOI":"10.3390\/vaccines14040295"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Singh, S., Gautam, S., Thakkar, V., Kumar, S., and Joshi, D. (2026). Viral Vaccine Adjuvant Strategies for Shaping Durable Immunity Across the Human Lifespan. Vaccines, 14.","DOI":"10.3390\/vaccines14060508"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/787\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T09:51:28Z","timestamp":1788947488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":8,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090787"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090787","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]}}}